Detection of anti-protease inhibitors resistance mutations in HCV strains infecting treatment-naïve chronic patients from Romania
Background: Severe complications of chronic hepatitis C – i.e. cirrhosis and hepatocellular carcinoma – are important causes of morbidity and mortality worldwide. Despite the overwhelming rates of sustained virologic response achieved after therapy with different combinations of direct-acting antivi...
Main Authors: | Dinu Sorin, Țârdei Grațiela, Ceaușu Emanoil, Florescu Simin Aysel, Micu Laurențiu, Ecobici Alina Monica, Mihăilă Mariana, Oprișan Gabriela |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-10-01
|
Series: | Romanian Journal of Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rrlm-2018-0029 |
Similar Items
-
Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
by: Allan Peres-da-Silva, et al.
Published: (2012-03-01) -
NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus
by: Satheesh Natarajan
Published: (2010-01-01) -
Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel
by: Laurent Chatel-Chaix, et al.
Published: (2010-08-01) -
Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
by: Jenny Kouretova, et al.
Published: (2017-01-01) -
Protease inhibitors for the treatment of hepatitis C virus infection
by: de Leuw, Philipp, et al.
Published: (2017-11-01)